Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS

Eline J M Bertrums; C Michel Zwaan; Daisuke Hasegawa; Valerie De Haas; Dirk N Reinhardt; Franco Locatelli; Barbara De Moerloose; Michael Dworzak; Arjan Buijs; Petr Smisek; Alexandra Kolenova; Cornelis Jan Pronk; Jan-Henning Klusmann; Ana Carboné; Alina Ferster; Evangelia Antoniou; Soheil Meshinchi; Susana C Raimondi; Charlotte M Niemeyer; Henrik Hasle; Marry M Van den Heuvel-Eibrink; Bianca F Goemans

doi:10.3324/haematol.2021.279507

Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS

Haematologica. 2022 Mar 1;107(3):759-764. doi: 10.3324/haematol.2021.279507.

Authors

Eline J M Bertrums¹, C Michel Zwaan², Daisuke Hasegawa³, Valerie De Haas⁴, Dirk N Reinhardt⁵, Franco Locatelli⁶, Barbara De Moerloose⁷, Michael Dworzak⁸, Arjan Buijs⁹, Petr Smisek¹⁰, Alexandra Kolenova¹¹, Cornelis Jan Pronk¹², Jan-Henning Klusmann¹³, Ana Carboné¹⁴, Alina Ferster¹⁵, Evangelia Antoniou⁵, Soheil Meshinchi¹⁶, Susana C Raimondi¹⁷, Charlotte M Niemeyer¹⁸, Henrik Hasle¹⁹, Marry M Van den Heuvel-Eibrink²⁰, Bianca F Goemans⁴

Affiliations

¹ Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Erasmus MC, Rotterdam, the Netherlands; Oncode Institute, Utrecht. e.j.m.bertrums@prinsesmaximacentrum.nl.
² Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Erasmus MC, Rotterdam.
³ Department of Pediatrics, St. Luke's international Hospital, Tokyo.
⁴ Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Dutch Childhood Oncology Group (DCOG), Utrecht.
⁵ Department of Pediatric Oncology, University of Duisburg-Essen, Essen.
⁶ Sapienza, University of Rome Department of Pediatric Hematology-Oncology, IRCCS Bambino Gesù Children's Hospital, Rome.
⁷ Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent.
⁸ Children's Cancer Research Institute and St. Anna Kinderspital, Department of Pediatrics, Medical University of Vienna, Vienna.
⁹ Department of Genetics, University Medical Center, Utrecht.
¹⁰ Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague.
¹¹ Department of Pediatric Hematology and Oncology, Comenius University Children's Hospital, Bratislava.
¹² Childhood Cancer Center, Skåne University Hospital, Lund.
¹³ Pediatric Hematology, Oncology and Hemostaseology, Hospital for Children and Adolescents, University Hospital of Frankfurt/Main, Goethe-University Frankfurt/Main, Frankfurt.
¹⁴ Department of Pediatric Onco-Hematology, University Hospital Miguel Servet, Zaragoza.
¹⁵ Department of Hemato-Oncology, Immunology and Transplantation, University Pediatric Hospital Reine Fabiola (ULB), Brussels.
¹⁶ Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA.
¹⁷ Department of Pathology, St. Jude Children's Hospital, Memphis, TN.
¹⁸ Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg.
¹⁹ Department of Pediatrics, Aarhus University Hospital, Aarhus.
²⁰ Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands University of Utrecht, Utrecht.

No abstract available

MeSH terms

Humans
Infant, Newborn
Leukemia, Myeloid, Acute* / complications
Leukemia, Myeloid, Acute* / diagnosis
Leukemia, Myeloid, Acute* / therapy
Myelodysplastic Syndromes*
Myeloproliferative Disorders* / complications
Myeloproliferative Disorders* / diagnosis
Myeloproliferative Disorders* / drug therapy